M
Moleculin Biotech D
D
MBRX
0.65640
USD
-0.03
(-3.77%)
مغلق
حجم التداول
2,287
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
9,273,287
الأخبار المقالات
العنوان: Moleculin Biotech
القطاع: Healthcare
الصناعة: Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.